Wells Fargo Initiates Coverage On Metagenomi with Overweight Rating, Announces Price Target of $25
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Yanan Zhu has initiated coverage on Metagenomi, listed on NASDAQ under the symbol MGX, with an Overweight rating and a price target of $25.

March 05, 2024 | 11:57 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo initiated coverage on Metagenomi with an Overweight rating and a price target of $25.
The initiation of coverage by a major financial institution like Wells Fargo, especially with an Overweight rating and a specific price target, typically signals confidence in the company's future performance. This can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100